Skip to main content
Signal8
Furuta Milano profile photo

Milano Furuta

CIK: 0002111400

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TAKEDA PHARMACEUTICAL CO LTD logo
TAK

TAKEDA PHARMACEUTICAL CO LTD

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • TAKEDA PHARMACEUTICAL CO LTD logo
    TAK

    TAKEDA PHARMACEUTICAL CO LTD

    Jul 10, 2026
    Disposition(D)

    Tax Obligation Award

    Direct
    16.6K shares at avg. $4931.50-
  • TAKEDA PHARMACEUTICAL CO LTD logo
    TAK

    TAKEDA PHARMACEUTICAL CO LTD

    Jul 1, 2026
    Award(A)
    Direct
    12.3K shares-
  • TAKEDA PHARMACEUTICAL CO LTD logo
    TAK

    TAKEDA PHARMACEUTICAL CO LTD

    Apr 27, 2026
    Award(A)
    Direct
    7.8K shares-

1-3 of 3

About Furuta Milano

Furuta Milano (SEC CIK 0002111400) files insider reports with the SEC as Chief Financial Officer of TAKEDA PHARMACEUTICAL CO LTD (TAK).

Signal8 holds 3 ownership filings by Furuta Milano (1 Form 3, 2 Form 4), filed between Mar 18, 2026 and Jul 6, 2026. Those filings report 3 transactions, from Apr 27, 2026 to Jul 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Furuta Milano's filings is in TOKYO.

Recent filings by Furuta Milano

  • Jul 10, 2026: Disposition to issuer transaction of TAK derivative securities (Form 4, code D).
  • Jul 1, 2026: Grant or award of TAK shares (Form 4, code A).
  • Apr 27, 2026: Grant or award of TAK shares (Form 4, code A).

Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)

How to read Form 4 transaction codes